期刊文献+

光动力疗法治疗日光角化病的临床疗效及其影响因素分析

Assessment of the Clinical Efficacy and Infl uencing Factors of Photodynamic Therapy in the Treatment of Actinic Keratosis
下载PDF
导出
摘要 目的:评价光动力治疗日光角化病(Actinickeratosis,AK)的临床疗效,并探讨影响疗效的相关因素。方法:回顾性分析2017年6月-2022年3月笔者医院采用光动力治疗AK的患者临床资料,并随访其临床疗效,进行单因素分析筛选后使用有序多分类Logistic回归分析探讨影响疗效的主要因素。结果:共纳入116例AK患者,其中49例(42.24%)完全缓解,35例(30.17%)部分缓解,32例无效(27.59%),总有效率72.41%;治疗次数3次及以上的AK患者治疗有效率为90.54%。有序多分类Logistic回归分析结果显示治疗次数,皮损分级、皮损数量是影响治疗疗效的主要因素;治疗1~2次者疗效比治疗3次及以上者差(OR=0.036,P<0.05);皮损分级低者(Olsen1~2级)疗效优于皮损分级(3级)高者(OR=3.848,P<0.05);皮损数量少者疗效较皮损多发者(≥3个)疗效更佳(OR=17.167,P<0.05)。治疗期间AK患者均未发生严重的不良反应。结论:单发、皮损厚度偏薄的日光角化病患者进行光动力治疗效果更佳,且治疗次数以3次以上为宜。性别、年龄、皮肤类型、皮损直径等均不影响疗效。 Objective To assess the clinical efficacy of photodynamic therapy in the treatment of actinic keratosis(AK),and explore its main infl uencing factors.Methods The AK patients treated by photodynamic therapy in the investigator's hospital from June 2017 to March 2022 were retrospectively analyzed and followed up.The main affecting factors on the treatment efficacy were done by univariate analysis and ordered multivariate logistic regression analysis.Results A total of 116 AK patients were included in the study.Of these,49 patients(42.24%)achieved complete remission,35 patients(30.17%)achieved partial remission,32 patients were ineff ective(27.59%),and the total effective rate was 72.41%.Through ordered multivariate logistic regression analysis,the eff ective rate was 90.54% for patients with 3 or more times treatments;The results showed that the number of treatment times,the classifi cation and the number of skin lesions were the main factors affecting the therapeutic effi cacy.The patients who received 1-2 times had inferior efficacy to those who had 3 or more times of treatment(OR=0.036,P<0.05);The effi cacy of patients with low-grade skin lesions(Olsen Grade 1-2)was better than those with high-grade skin lesions(Grade 3)(OR=3.848,P<0.05);less number of lesions predicted better outcome than those with multiple lesions(≥3 lesions)(OR=17.167,P<0.05).No patients had serious adverse reactions during treatment.Conclusion AK Patients who had fewer,thinner skin lesions would have better therapeutic efficacy,and the times of treatment should be 3 or more.Sex,age,skin type,and lesion size did not aff ect the therapeutic efficacy.
作者 孔淑贞 王亮琪 张静 曾维惠 耿松梅 KONG Shuzhen;WANG Liangqi;ZHANG Jing;ZENG Weihui;GENG Songmei(Department of Dermatology,the Second Affi liated Hospital of Xi’an Jiaotong University,Xi’an 710004,Shaanxi,China)
出处 《中国美容医学》 CAS 2023年第7期114-118,共5页 Chinese Journal of Aesthetic Medicine
基金 2019年陕西省重点研发一般项目(编号:2019SF-210) 陕西省创新团队皮肤微环境与免疫(编号:2022TD-48)。
关键词 光动力疗法 日光角化病 临床疗效 影响因素 photodynamic therapy actinic keratoses efficacy infl uence factor
  • 相关文献

参考文献9

二级参考文献74

  • 1王宏伟,王秀丽,过明霞,虞叶风.5-氨基酮戊酸乳膏光动力疗法治疗皮肤癌前病变和皮肤原位癌[J].中华皮肤科杂志,2006,39(3):137-139. 被引量:49
  • 2王宏伟,王秀丽,过明霞.外用咪喹莫特乳膏致局限型白癜风二例[J].中华皮肤科杂志,2006,39(10):613-613. 被引量:2
  • 3赵辨.中国临床皮肤病学[M].南京:江苏科学技术出版社,2009,12:744. 被引量:404
  • 4Orenstein A,Haik J,Tamir J,et al.Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application[J].Dermatol Surg,2000,26 (8):765-770. 被引量:1
  • 5Ibbotson SH.Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than nonmelanoma skin cancer[J].Br J Dermatol,2002,146:178-188. 被引量:1
  • 6Wang XL,Wang HW,Wang HS,et al.Topical 5-aminolaevulinic Acid-photodynamic therapy for the treatment of urethral condylomata acuminate[J].Br JDermatol,2004,151:880-885. 被引量:1
  • 7Kalla K,Merk H,Mukhlar H.Photodynamic therapy in dermatology[J].J Am Acad Dermatol,2000,42 (3):389-413. 被引量:1
  • 8Morton CA.Photodynamic therapy for nonmelanoma skin cancer and more[J].Arch Dermatol,2004,1401:16-120. 被引量:1
  • 9Selvasekar CR,Birbeck N,McMillan T,et al.Photodynamic therapy and the alimentary tract[J].Aliment Pharmacol Ther,2001,15:899. 被引量:1
  • 10Fritsch C,Goem G,Ruzieka T.Photodynamic therapy in dermatology[J].Arch Dermatol,2000,10:568-576. 被引量:1

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部